Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The airway mucus gel layer is a critical viscoelastic barrier lining the respiratory epithelium, primarily composed of water, ions, and large gel-forming mucins such as MUC5AC and MUC5B (Fahy & Dickey, 2010, NEJM). Its primary biological function is to trap inhaled particulates, allergens, and pathogens, facilitating their removal from the lungs via the mucociliary escalator (Boucher, 2019, NIH). In pathological states like cystic fibrosis, COPD, and asthma, the mucus layer becomes abnormally thick, dehydrated, and adhesive, leading to airway obstruction, impaired clearance, and a niche for chronic bacterial colonization (Button et al., 2012, Science). Pharmacological intervention focuses on modifying the physical properties of this gel—such as its rheology and hydration—to restore effective clearance and reduce the burden of obstructive lung disease. Common therapeutic strategies include the use of mucolytics to break down the mucin network and osmotic agents to draw water into the gel layer (Widdicombe, 2002, J Physiol). Understanding the structural integrity and clearance dynamics of this layer is essential for developing treatments that alleviate the symptoms of chronic respiratory conditions.
Reduction of mucus viscosity via disulfide bond disruption (classic mucolytics), degradation of extracellular DNA (nucleolytics), and enhancement of gel hydration through osmotic gradients (osmotic agents) to facilitate clearance by coughing or ciliary action.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway mucus gel layer.